Clinical Trials Logo

Preterm Birth clinical trials

View clinical trials related to Preterm Birth.

Filter by:

NCT ID: NCT00120588 Completed - Preterm Birth Clinical Trials

Neuroprotection by Magnesium Sulfate Given to Women at Risk of Very Preterm Birth

Start date: July 1997
Phase: Phase 4
Study type: Interventional

Magnesium is neuroprotective in neonatal animal models of acquired hypoxic-ischemic and/or inflammatory cerebral lesions. It is associated with a significant reduction of perinatal death and cerebral palsy in some observational studies. The objective of the study is to assess if prenatal magnesium sulfate given to women at risk of preterm birth before 33 week's gestation is neuroprotective.

NCT ID: NCT00099164 Completed - Pregnancy Clinical Trials

Trial of Progesterone in Twins and Triplets to Prevent Preterm Birth (STTARS)

Start date: April 2004
Phase: Phase 3
Study type: Interventional

Women pregnant with twins or triplets are at high risk of preterm birth, yet no intervention or approach has served to reduce this risk. A recently completed trial by the NICHD sponsored Maternal Fetal Medicine Units (MFMU) Network has, for the first time, demonstrated a treatment that substantially reduces the rate of preterm birth in women at high risk for preterm delivery (i.e. progesterone therapy). Preterm birth was reduced by 35% among progesterone-treated women with a singleton pregnancy when compared with women receiving placebo. The current trial compares weekly treatment by injection of progesterone with placebo in women pregnant with twins or triplets.